Page last updated: 2024-10-22

6-acetylaminocaproic acid and Acute Kidney Injury

6-acetylaminocaproic acid has been researched along with Acute Kidney Injury in 1 studies

6-acetylaminocaproic acid: wound-healing agent component of plasmutan

Acute Kidney Injury: Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.

Research Excerpts

ExcerptRelevanceReference
" Thus, pharmacokinetic changes in rats with acute renal failure induced by uranyl nitrate (U-ARF rats) were investigated in this study."1.38Reduced clearance of ε-acetamidocaproic acid in rats with acute renal failure induced by uranyl nitrate. ( Choi, YH; Han, SY; Lee, MG; Yang, SH; Yoon, I, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Han, SY1
Yang, SH1
Yoon, I1
Lee, MG1
Choi, YH1

Other Studies

1 other study available for 6-acetylaminocaproic acid and Acute Kidney Injury

ArticleYear
Reduced clearance of ε-acetamidocaproic acid in rats with acute renal failure induced by uranyl nitrate.
    The Journal of pharmacy and pharmacology, 2012, Volume: 64, Issue:10

    Topics: Acute Kidney Injury; Administration, Oral; Aminocaproates; Aminocaproic Acid; Animals; Area Under Cu

2012